Oleylamine-carbonyl-valinol inhibits auto-phosphorylation activity of native and T315I mutated Bcr-Abl, and exhibits selectivity towards oncogenic Bcr-Abl in SupB15 ALL cell lines.

about

Oleylamine-carbonyl-valinol inhibits auto-phosphorylation activity of native and T315I mutated Bcr-Abl, and exhibits selectivity towards oncogenic Bcr-Abl in SupB15 ALL cell lines.

Item

http://www.wikidata.org/entity/Q39232212

description

2012 nî lūn-bûn

@nan

2012年の論文

@ja

2012年論文

@yue

2012年論文

@zh-hant

2012年論文

@zh-hk

2012年論文

@zh-mo

2012年論文

@zh-tw

2012年论文

@wuu

2012年论文

@zh

2012年论文

@zh-cn

name

Oleylamine-carbonyl-valinol in ...... -Abl in SupB15 ALL cell lines.

@en

Oleylamine-carbonyl-valinol in ...... -Abl in SupB15 ALL cell lines.

@nl

type

Item

label

Oleylamine-carbonyl-valinol in ...... -Abl in SupB15 ALL cell lines.

@en

Oleylamine-carbonyl-valinol in ...... -Abl in SupB15 ALL cell lines.

@nl

prefLabel

Oleylamine-carbonyl-valinol in ...... -Abl in SupB15 ALL cell lines.

@en

Oleylamine-carbonyl-valinol in ...... -Abl in SupB15 ALL cell lines.

@nl

P1476

Oleylamine-carbonyl-valinol in ...... -Abl in SupB15 ALL cell lines.

@en

P2093

Hazem Khamaisie

http://www.w3.org/2001/XMLSchema#string

Jamal Mahajna

http://www.w3.org/2001/XMLSchema#string

Joshua Katzhendler

http://www.w3.org/2001/XMLSchema#string

Martin Ruthardt

http://www.w3.org/2001/XMLSchema#string

Nili Ruimi

http://www.w3.org/2001/XMLSchema#string

Soliman Khatib

http://www.w3.org/2001/XMLSchema#string

Yousef Najajreh

http://www.w3.org/2001/XMLSchema#string

P2860

AP24534, a pan-BCR-ABL inhibitor for chronic myeloid leukemia, potently inhibits the T315I mutant and overcomes mutation-based resistance

Targeting Bcr–Abl by combining allosteric with ATP-binding-site inhibitors

Structural mechanism of the Pan-BCR-ABL inhibitor ponatinib (AP24534): lessons for overcoming kinase inhibitor resistance

Discovery of potent and highly selective thienopyridine Janus kinase 2 inhibitors

Automated docking of flexible ligands: applications of AutoDock

Allosteric inhibitors of Bcr-abl-dependent cell proliferation.

The biology of chronic myeloid leukemia.

Chronic myelogenous leukemia: biology and therapy.

Discovery of 3-[2-(imidazo[1,2-b]pyridazin-3-yl)ethynyl]-4-methyl-N-{4-[(4-methylpiperazin-1-yl)methyl]-3-(trifluoromethyl)phenyl}benzamide (AP24534), a potent, orally active pan-inhibitor of breakpoint cluster region-abelson (BCR-ABL) kinase includ

Molecular mechanisms of resistance to imatinib in Philadelphia-chromosome-positive leukaemias.

P2888

s11033-012-2282-8

P304

2205-2213

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S11033-012-2282-8

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2012-12-05T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

233849407

http://www.w3.org/2001/XMLSchema#string

P698

23212614

http://www.w3.org/2001/XMLSchema#string